SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Novavax NVAX -- Ignore unavailable to you. Want to Upgrade?


To: MJ who wrote (8)5/13/2009 6:20:43 AM
From: Rock_nj  Respond to of 166
 
Thanks. So far these swine flu plays have been busts, but the swine flu isn't going away any time soon, and contracts will be awarded for vaccines and treatments.

Novavax has their annual meeting today. Any revenue news should help this stock since their revenues are very light right now.



To: MJ who wrote (8)5/13/2009 9:36:16 AM
From: Jack Hartmann  Read Replies (3) | Respond to of 166
 
I would think Novartis will get the chunk of the vaccine money.